We wanted to share some of these programs.
commission.europa.eu/funding-tend...
We wanted to share some of these programs.
commission.europa.eu/funding-tend...
'One of the most compelling new biomarkers...is peroxiredoxin-3 (PRDX3), a mitochondrial antioxidant enzyme found at elevated levels..'
gethealthspan.com/science/arti...
'One of the most compelling new biomarkers...is peroxiredoxin-3 (PRDX3), a mitochondrial antioxidant enzyme found at elevated levels..'
gethealthspan.com/science/arti...
No resistance emerged after 50 viral generations, making it a promising broad-spectrum antiviral.
www.biorxiv.org/content/10.1...
No resistance emerged after 50 viral generations, making it a promising broad-spectrum antiviral.
www.biorxiv.org/content/10.1...
When PGC1 levels are low, IL6 stabilizes HIF1α, which inhibits ERRα, reducing mitochondrial activity.
Boosting PGC1 reverses this effect.
www.cell.com/cell-reports...
When PGC1 levels are low, IL6 stabilizes HIF1α, which inhibits ERRα, reducing mitochondrial activity.
Boosting PGC1 reverses this effect.
www.cell.com/cell-reports...
We’re excited to share a major breakthrough in 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵.
🔍 Read the full press release: precisionlife.com/news-and-eve...
We’re excited to share a major breakthrough in 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵.
🔍 Read the full press release: precisionlife.com/news-and-eve...
Renegade Research (RR) is a non-profit 501c3 decentralized organization pioneering #patient & #caregiver led #research with a focus on ME/CFS, Long COVID (LC) & other infection associated chronic illnesses #IACI...
www.zeffy.com/en-US/fundra...
Renegade Research (RR) is a non-profit 501c3 decentralized organization pioneering #patient & #caregiver led #research with a focus on ME/CFS, Long COVID (LC) & other infection associated chronic illnesses #IACI...
www.zeffy.com/en-US/fundra...
Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome
academic.oup.com/ofid/article...
#MEcfs #CFS
Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome
academic.oup.com/ofid/article...
#MEcfs #CFS
His trial reported "an unexpectedly high rate of improvement in the comparison [treatment as usual] group."
His trial reported "an unexpectedly high rate of improvement in the comparison [treatment as usual] group."
Read more about this study👉 ow.ly/Hker50UL3zJ.
Read more about this study👉 ow.ly/Hker50UL3zJ.